$KRON
Kronos Bio, Inc.

2021 Q3 Form 10-Q Financial Statement

#000174183021000041 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.752M $10.11M $4.223M
YoY Change 78.94% 139.31%
% of Gross Profit
Research & Development $24.69M $19.80M $7.175M
YoY Change 47.35% 175.99%
% of Gross Profit
Depreciation & Amortization $500.0K $500.0K $100.0K
YoY Change 150.0% 400.0% -23.08%
% of Gross Profit
Operating Expenses $33.67M $29.14M $8.798M
YoY Change 61.82% 231.22%
Operating Profit -$33.67M -$29.14M -$8.798M
YoY Change 61.82% 231.22%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $70.00K $86.00K $219.0K
YoY Change -100.37% -60.73%
Pretax Income -$33.60M -$29.06M -$15.57M
YoY Change -15.38% 86.56%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$33.60M -$29.06M -$8.579M
YoY Change -15.39% 238.68% 144.49%
Net Earnings / Revenue
Basic Earnings Per Share -$0.61 -$0.53
Diluted Earnings Per Share -$611.2K -$0.53 -$293.6K
COMMON SHARES
Basic Shares Outstanding 56.25M shares 54.51M shares
Diluted Shares Outstanding 54.98M shares 54.51M shares

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $398.4M $416.9M $81.50M
YoY Change 88.54% 411.51%
Cash & Equivalents $217.0M $185.7M $37.97M
Short-Term Investments $181.4M $231.2M $43.50M
Other Short-Term Assets $3.397M $6.202M $900.0K
YoY Change 142.64% 589.11%
Inventory
Prepaid Expenses
Receivables $1.048M $1.224M $200.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $402.8M $424.3M $82.50M
YoY Change 89.22% 414.31%
LONG-TERM ASSETS
Property, Plant & Equipment $42.56M $42.92M $35.30M
YoY Change 7.21% 21.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $2.377M $0.00
YoY Change -100.0%
Other Assets $112.0K $112.0K $2.700M
YoY Change -96.51% -95.85%
Total Long-Term Assets $44.70M $47.44M $38.00M
YoY Change -9.99% 24.84%
TOTAL ASSETS
Total Short-Term Assets $402.8M $424.3M $82.50M
Total Long-Term Assets $44.70M $47.44M $38.00M
Total Assets $447.5M $471.7M $120.5M
YoY Change 70.45% 291.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.940M $3.342M $2.500M
YoY Change -11.32% 33.68%
Accrued Expenses $7.350M $6.516M $3.000M
YoY Change 312.92% 117.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change
Total Short-Term Liabilities $14.77M $13.08M $6.200M
YoY Change -91.95% 110.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.406M $1.714M $29.40M
YoY Change -50.51% -94.17%
Total Long-Term Liabilities $1.406M $1.714M $29.40M
YoY Change -50.51% -94.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.77M $13.08M $6.200M
Total Long-Term Liabilities $1.406M $1.714M $29.40M
Total Liabilities $48.51M $47.64M $35.60M
YoY Change -77.54% 33.81%
SHAREHOLDERS EQUITY
Retained Earnings -$200.7M -$167.0M
YoY Change 154.8%
Common Stock $55.00K $55.00K
YoY Change 816.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $399.0M $424.1M -$37.98M
YoY Change
Total Liabilities & Shareholders Equity $447.5M $471.7M $120.5M
YoY Change 70.45% 291.49%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$33.60M -$29.06M -$8.579M
YoY Change -15.39% 238.68% 144.49%
Depreciation, Depletion And Amortization $500.0K $500.0K $100.0K
YoY Change 150.0% 400.0% -23.08%
Cash From Operating Activities -$20.14M -$20.26M -$12.00M
YoY Change 95.91% 68.85% 80.45%
INVESTING ACTIVITIES
Capital Expenditures -$926.0K -$1.346M -$1.720M
YoY Change -77.79% -21.74% 102.35%
Acquisitions
YoY Change
Other Investing Activities $51.02M $64.38M $21.02M
YoY Change -407.16% 206.27%
Cash From Investing Activities $50.09M $63.03M $19.30M
YoY Change -341.07% 226.59% -2370.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.381M 1.439M 120.0K
YoY Change -99.07% 1099.17% -99.78%
NET CHANGE
Cash From Operating Activities -20.14M -20.26M -12.00M
Cash From Investing Activities 50.09M 63.03M 19.30M
Cash From Financing Activities 1.381M 1.439M 120.0K
Net Change In Cash 31.34M 44.21M 7.420M
YoY Change -73.5% 495.8% -84.31%
FREE CASH FLOW
Cash From Operating Activities -$20.14M -$20.26M -$12.00M
Capital Expenditures -$926.0K -$1.346M -$1.720M
Free Cash Flow -$19.21M -$18.92M -$10.28M
YoY Change 214.47% 84.01% 77.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001741830
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39592
dei Entity Registrant Name
EntityRegistrantName
Kronos Bio, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1895605
dei Entity Address Address Line1
EntityAddressAddressLine1
1300 So. El Camino Real
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
San Mateo
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94402
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
781-5200
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
KRON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56254188 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185658000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
248009000 USD
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
231219000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
165052000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7426000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6741000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
424303000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
419802000 USD
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
2377000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
49001000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14967000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13646000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27957000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27322000 USD
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2027000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
166000 USD
CY2021Q2 us-gaap Assets
Assets
471742000 USD
CY2020Q4 us-gaap Assets
Assets
511964000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3342000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4550000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6516000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4974000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1133000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
937000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2087000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2395000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13078000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12856000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32843000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31120000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1714000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2469000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
47635000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
46445000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54759344 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54759344 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54073901 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54073901 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
55000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
54000 USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
591093000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
577390000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167047000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111906000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
424107000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
465519000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
471742000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
511964000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19802000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7175000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37396000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13370000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9339000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1623000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17923000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2777000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
29141000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
8798000 USD
us-gaap Operating Expenses
OperatingExpenses
55319000 USD
us-gaap Operating Expenses
OperatingExpenses
16147000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29141000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8798000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-55319000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16147000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
0 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
1000 USD
CY2021Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
86000 USD
CY2020Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
219000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
178000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
574000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
219000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
178000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
573000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29055000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8579000 USD
us-gaap Net Income Loss
NetIncomeLoss
-55141000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15574000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
29000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
24000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
25000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
182000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29026000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8555000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55116000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15392000 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.47
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.70
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5833946 shares
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54506195 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54330402 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5764389 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
465519000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
590000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5238000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26086000 USD
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
445257000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
627000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6432000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
817000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
29000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29055000 USD
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
424107000 USD
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21504893 shares
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
122907000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-23203000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
188000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
158000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6995000 USD
CY2020Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21504893 shares
CY2020Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
122907000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-29832000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
113000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
293000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
24000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8579000 USD
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21504893 shares
CY2020Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
122907000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-37981000 USD
us-gaap Net Income Loss
NetIncomeLoss
-55141000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15574000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
908000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
343000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2074000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-64000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-53000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-48000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11670000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
481000 USD
kron Lease Expense Noncash
LeaseExpenseNoncash
1112000 USD
kron Lease Expense Noncash
LeaseExpenseNoncash
1016000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-54000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
272000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
65000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1488000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
294000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2454000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26000 USD
kron Increase Decrease In Right Of Use Operating Assets And Liabilities Net
IncreaseDecreaseInRightOfUseOperatingAssetsAndLiabilitiesNet
-172000 USD
kron Increase Decrease In Right Of Use Operating Assets And Liabilities Net
IncreaseDecreaseInRightOfUseOperatingAssetsAndLiabilitiesNet
-148000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1065000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1462000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39262000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11996000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2856000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1721000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
141196000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
8158000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
118933000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
29180000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25119000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19301000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
16000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1217000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
133000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
817000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2029000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62352000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7422000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250036000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32570000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187684000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39992000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
648000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
782000 USD
kron Right Of Use Asset Increase Decrease Due To Modification
RightOfUseAssetIncreaseDecreaseDueToModification
-1741000 USD
kron Right Of Use Asset Increase Decrease Due To Modification
RightOfUseAssetIncreaseDecreaseDueToModification
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3764000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
30031000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185658000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37966000 USD
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 USD
CY2020Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2026000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187684000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39992000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Net Income Loss
NetIncomeLoss
-167000000.0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed financial statements include, but are not limited to, the accrual of research and development expenses, the fair value of convertible notes and investments, income tax uncertainties, the valuation of equity instruments and the incremental borrowing rate for determining the operating lease assets and liabilities. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from the Company’s estimates.</span></div>The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, results of operations and financial condition, including expenses, clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international markets.
CY2021Q2 kron Cash And Cash Equivalent And Debt Securities Available For Sale Amortized Cost
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleAmortizedCost
411387000 USD
CY2021Q2 kron Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Gain Before Tax
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedGainBeforeTax
20000 USD
CY2021Q2 kron Cash And Cash Equivalent And Debt Securities Available For Sale
CashAndCashEquivalentAndDebtSecuritiesAvailableForSale
411393000 USD
CY2021Q2 kron Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Loss Before Tax
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedLossBeforeTax
14000 USD
CY2020Q4 kron Cash And Cash Equivalent And Debt Securities Available For Sale Amortized Cost
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleAmortizedCost
450890000 USD
CY2020Q4 kron Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Gain Before Tax
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedGainBeforeTax
18000 USD
CY2020Q4 kron Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Loss Before Tax
CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedLossBeforeTax
37000 USD
CY2020Q4 kron Cash And Cash Equivalent And Debt Securities Available For Sale
CashAndCashEquivalentAndDebtSecuritiesAvailableForSale
450871000 USD
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
177797000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
236818000 USD
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
231219000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
165052000 USD
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
2377000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
49001000 USD
CY2021Q2 us-gaap Investments And Cash
InvestmentsAndCash
411393000 USD
CY2020Q4 us-gaap Investments And Cash
InvestmentsAndCash
450871000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
235028000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
287686000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
2377000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
49001000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
173988000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
114184000 USD
CY2021Q2 us-gaap Investments And Cash
InvestmentsAndCash
411393000 USD
CY2020Q4 us-gaap Investments And Cash
InvestmentsAndCash
450871000 USD
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2020 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2021Q2 kron Debt Securities Available For Sale Accrued Interest
DebtSecuritiesAvailableForSaleAccruedInterest
1224000 USD
CY2020Q4 kron Debt Securities Available For Sale Accrued Interest
DebtSecuritiesAvailableForSaleAccruedInterest
612000 USD
CY2021Q2 kron Prepaid Equipment Service Contracts
PrepaidEquipmentServiceContracts
379000 USD
CY2020Q4 kron Prepaid Equipment Service Contracts
PrepaidEquipmentServiceContracts
383000 USD
CY2021Q2 kron Prepaid External Research And Development And Outside Services
PrepaidExternalResearchAndDevelopmentAndOutsideServices
3693000 USD
CY2020Q4 kron Prepaid External Research And Development And Outside Services
PrepaidExternalResearchAndDevelopmentAndOutsideServices
1889000 USD
CY2021Q2 kron Prepaid Software
PrepaidSoftware
641000 USD
CY2020Q4 kron Prepaid Software
PrepaidSoftware
736000 USD
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1025000 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2881000 USD
CY2021Q2 us-gaap Prepaid Rent
PrepaidRent
464000 USD
CY2020Q4 us-gaap Prepaid Rent
PrepaidRent
240000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7426000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6741000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
0 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
139000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
17160000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
14931000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2193000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
1285000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14967000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13646000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
500000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
300000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1766000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2274000 USD
CY2021Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
146000 USD
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
558000 USD
CY2021Q2 kron Accrued External Research And Development Current
AccruedExternalResearchAndDevelopmentCurrent
3475000 USD
CY2020Q4 kron Accrued External Research And Development Current
AccruedExternalResearchAndDevelopmentCurrent
1017000 USD
CY2021Q2 kron Accrued Outside Services Current
AccruedOutsideServicesCurrent
937000 USD
CY2020Q4 kron Accrued Outside Services Current
AccruedOutsideServicesCurrent
0 USD
CY2021Q2 kron Accrued Leasehold Improvements Current
AccruedLeaseholdImprovementsCurrent
0 USD
CY2020Q4 kron Accrued Leasehold Improvements Current
AccruedLeaseholdImprovementsCurrent
927000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
198000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6516000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4974000 USD
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5000 USD
CY2021Q2 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
2087000 USD
CY2020Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
2174000 USD
CY2021Q2 kron Espp Withholdings Liability Current
ESPPWithholdingsLiabilityCurrent
0 USD
CY2020Q4 kron Espp Withholdings Liability Current
ESPPWithholdingsLiabilityCurrent
216000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2087000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2395000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6251159 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1290370 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
61972 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.92
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
581069 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.09
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6898488 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
88595000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.69
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
54300000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
36300000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6432000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
293000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11670000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
481000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29055000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8579000 USD
us-gaap Net Income Loss
NetIncomeLoss
-55141000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15574000 USD
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54506195 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5833946 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54330402 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5764389 shares
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.47
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.70
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8065895 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26371508 shares
CY2020Q3 kron Royalty Obligation Termination Period From First Commercial Sale
RoyaltyObligationTerminationPeriodFromFirstCommercialSale
P10Y
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1133000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
937000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27957000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27322000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32843000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31120000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
33976000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
32057000 USD
CY2021Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
11000 USD
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1380000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1528000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2764000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1947000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2300000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
500000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
600000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2055000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5020000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5581000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5749000 USD
CY2021Q2 kron Lessee Operating Lease Liability To Be Paid Year Four And Thereafter
LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter
32625000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
51030000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17054000 USD
CY2021Q2 us-gaap Tenant Improvements
TenantImprovements
0 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
33976000 USD

Files In Submission

Name View Source Status
0001741830-21-000041-index-headers.html Edgar Link pending
0001741830-21-000041-index.html Edgar Link pending
0001741830-21-000041.txt Edgar Link pending
0001741830-21-000041-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kron-20210630.htm Edgar Link pending
kron-20210630.xsd Edgar Link pending
kron-20210630_cal.xml Edgar Link unprocessable
kron-20210630_def.xml Edgar Link unprocessable
kron-20210630_g1.jpg Edgar Link pending
kron-20210630_htm.xml Edgar Link completed
kron-20210630_lab.xml Edgar Link unprocessable
kron-20210630_pre.xml Edgar Link unprocessable
kronq2fy2021ex311.htm Edgar Link pending
kronq2fy2021ex312.htm Edgar Link pending
kronq2fy2021ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending